Sabby Management’s Dicerna Pharmaceuticals DRNA Stock Holding History
Bought
Maintained
Sold
Other funds holding DRNA
6CM
Sabby Management's DRNA Position: Q3 2017 in Review
Sabby Management sold out of Dicerna Pharmaceuticals (DRNA) in Q3 2017, closing a stake of 190,000 shares — an estimated $602K sold.
Sabby Management first reported a position in DRNA in Q1 2014 and held it in 8 quarters. The position peaked at $3.45M in Q2 2014. 37 funds tracked by Wall St. Rank hold DRNA as of Q3 2017.
- Sabby Management reported no remaining Dicerna Pharmaceuticals position as of Q3 2017 after selling out during the quarter.
- Sabby Management sold 190,000 Dicerna Pharmaceuticals shares in Q3 2017, an estimated $602K.
- Sabby Management first reported a position in Dicerna Pharmaceuticals in Q1 2014 and held it in 8 quarters.
- Sabby Management's Dicerna Pharmaceuticals position peaked at $3.45M in Q2 2014.
- 37 funds tracked by Wall St. Rank held Dicerna Pharmaceuticals as of Q3 2017.
Based on Sabby Management's 13F filing for Q3 2017, filed 14 Nov 2017.